Amoroso Michael's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Mar 23, 2023
- Accession no.
- 0001209191-23-020716
- Filed
- Mar 23, 2023
- Trade date
- Mar 21-22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $38.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Amoroso MichaelCIK 0001830874 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | Common Stock | MOption exerciseAcquired | +102,535 | –F2 | – | 115,737 | Direct | |
| Mar 22, 2023 | Common Stock | SSaleDisposed | −46,999 | $0.82 | −$38,539.18 | 68,738 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | Common Stock | MOption exerciseDisposed | −102,535 | $0.00 | $0 | 205,009 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.